RIOCIGUAT AMELIORATES RIGHT VENTRICULAR FUNCTION ASSESSED BY SPECKLE-TRACKING ECHOCARDIOGRAPHY IN PATIENTS WITH PULMONARY HYPERTENSIONRIOCIGUAT AMELIORATES RIGHT VENTRICULAR FUNCTION ASSESSED BY SPECKLE-TRACKING ECHOCARDIOGRAPHY IN PATIENTS WITH PULMONARY HYPERTENSION

Riociguat is a soluble guanylate cyclase stimulator approved for the treatment with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). However, the effect of riociguat on RV function and its relationships with hemodynamics have not been fully...